Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1
about
Pathogenesis of human immunodeficiency virus infectionMaternal plasma viral load and neutralizing/enhancing antibodies in vertical transmission of HIV: a non-randomized prospective studyBroadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.Broad neutralization of human immunodeficiency virus type 1 (HIV-1) elicited from human rhinoviruses that display the HIV-1 gp41 ELDKWA epitopeInfectious cellular load in human immunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmiVertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodiesEnhancement of antigen specific humoral immune responses after delivery of a DNA plasmid based vaccine through a contact-independent helium plasma.Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody.The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression.Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission.The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine designHuman cord blood mononuclear cells are preferentially infected by non-syncytium-inducing, macrophage-tropic human immunodeficiency virus type 1 isolates.Maternal Neutralization-Resistant Virus Variants Do Not Predict Infant HIV Infection RiskMarkers predicting progression of human immunodeficiency virus-related disease.Recombinant antibodies in bioactive peptide design.Engineering Recombinant Reoviruses To Display gp41 Membrane-Proximal External-Region Epitopes from HIV-1Biomarkers predicting progression of human immunodeficiency virus-related disease.Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission RiskGene-expression profiling of HIV-1 infection and perinatal transmission in Botswana.Rational design of granulocyte-macrophage colony-stimulating factor antagonist peptides.Expression and immunological characterization of cardamom mosaic virus coat protein displaying HIV gp41 epitopes.Neutralizing antibodies and complement-mediated, antibody-dependent enhancement (C'-ADE) of human immunodeficiency virus infection in its vertical transmission.
P2860
Q24634681-F6EBC736-A53A-4091-87A8-348387E365B0Q24804378-AB764364-C1D7-4C9D-867E-BCAA936CC8F4Q31016954-705C67B6-B4D6-4C33-8256-869FF5B2A7FCQ33417195-246BAE60-0727-4DDA-BC56-A445E260FB3BQ33781934-D494C5B9-1D2D-4E0E-AD39-8F67FA058110Q34201595-FA187FA1-BC60-4CF8-8167-626440EC0353Q35167024-305B48C4-FC40-4F88-94A6-EE25C1C0BE37Q35170702-9F57565B-AAED-4968-AC09-6D08D468CF33Q35591075-41B2B6FD-F3F6-4A47-8C86-79956CA79D82Q36184762-427894E9-DD67-45E1-9415-8EDD5CB7F5A3Q36497712-390D83C3-383D-4CDE-93D2-353939D0D52CQ36518135-94438C31-D298-4994-A6D7-06232EDE852BQ36548276-525EE1D1-B607-4CE2-95EA-AEC6612B4460Q36640801-DC12A975-C006-4560-875A-1A3A06F4D188Q36720505-05F9C01A-3958-4C9C-A88F-90B42CF40926Q36956100-9DCA26B4-30FE-45CC-8D92-DA0D6C2264B1Q37910761-84DD59EF-72F4-4441-9AA9-7573450770D2Q40331385-1D52F6D2-EC21-4BFD-9908-21B278094A3FQ40799780-6B3B63C2-A511-44EF-9825-281911F30E4AQ41229072-260FF36D-E6CD-43E0-A2BF-7B56BB8DF7DFQ45351263-A3A377F9-87CE-4DBC-9CB6-AB94ECFDA212Q45755248-0F60409B-35EA-40FD-8DB4-40C55577BCDB
P2860
Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Vertical transmission of human ...... nd 41 peptides from HIV type 1
@ast
Vertical transmission of human ...... nd 41 peptides from HIV type 1
@en
Vertical transmission of human ...... nd 41 peptides from HIV type 1
@nl
type
label
Vertical transmission of human ...... nd 41 peptides from HIV type 1
@ast
Vertical transmission of human ...... nd 41 peptides from HIV type 1
@en
Vertical transmission of human ...... nd 41 peptides from HIV type 1
@nl
prefLabel
Vertical transmission of human ...... nd 41 peptides from HIV type 1
@ast
Vertical transmission of human ...... nd 41 peptides from HIV type 1
@en
Vertical transmission of human ...... nd 41 peptides from HIV type 1
@nl
P2093
P2860
P3181
P356
P1476
Vertical transmission of human ...... nd 41 peptides from HIV type 1
@en
P2093
A Rubinstein
A Willoughby
J J Goedert
S Landesman
W V Williams
P2860
P304
P3181
P356
10.1172/JCI115798
P407
P577
1992-06-01T00:00:00Z